Protagenic Therapeutics, Inc. (PTIX)
OQB · Healthcare · Biotechnology
$0.14
-36.07%
Closing price as of 2026-07-28 · Source: TEK2day Finance
Key Metrics
Market Cap
$253,429.12
Shares Outstanding
1.8M
Exchange
OQB
Currency
USD
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.4M | -1.2M | -1.1M | -925K |
| Net Income | -1.4M | -5.1M | -869K | 2.2M |
| Diluted EPS | $-2.75 | $-1.37 | $-0.47 | $1.14 |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -4.1M | -3.6M | -4.5M | -5.7M |
| Net Income | -4.5M | -3.6M | -5.0M | -5.5M |
| Diluted EPS | $-17.36 | $-11.48 | $-16.10 | $-15.82 |